About Contact Us Careers
Sign In

Cysteine Market Size & Share, by Production Process (Natural, Synthetic); Application (Conditioner, Flavor Enhancer, Reducing Agent, Production of Human Insulin); End-user (Food, Pharmaceutical, Animal Feed) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4263
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Companies Dominating the Cysteine Landscape

top-features-companies
    • Wacker Chemie AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Nippon Rika Kogyosho CO., LTD.
    • Ajinomoto Co., Inc.
    • Wuxi Bikang Bioengineering Co., Ltd
    • Merck KGaA
    • Croda International plc
    • SERVA Electrophoresis GmbH
    • Chemyunion Inc.
    • Asiamerica Group, Inc.
    • Exela Pharma Sciences, LLC
Browse Key Market Insights with Data Illustration:

In the News

  • Exela Pharma Sciences, LLC, a leading healthcare products provider, today announced the launch of ELCYS (cysteine hydrochloride injection), the only FDA-approved cysteine hydrochloride injection available in the United States market.

  • Wacker Chemie AG, the life science division of the WACKER group, has started the production line for cysteine in Spain. The new site aims to produce cysteine resulting from fermentation to meet growing global customer demand.


Author Credits:  Smruti Ranjan, Rajrani Baghel


  • Report ID: 4263
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising support from the government through various policies and schemes and increasing consumption rate of bakery products are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023-2035.

Side effects of cysteine consumption such as increased levels of nitrogen in the body and reduced efficacy of kidneys are estimated to be the growth-hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Nippon Rika Kogyosho CO., LTD., Ajinomoto Co., Inc., Wuxi Bikang Bioengineering Co., Ltd, Merck KGaA, Croda International plc, SERVA Electrophoresis GmbH, Chemyunion Inc., Asiamerica Group, Inc., Exela Pharma Sciences, LLC, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by the production process, application, end-use industry, and by region.

he food segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying